Bioinformatic Analysis of Genetic Factors from Human Blood Samples and Postmortem Brains in Parkinson’s Disease

Table 4

Summary of enrichment analysis in transcription factor targets.

GO	Description	Count	%	Log10(P)	Log10(q)
M9431	AP1 Q6	38	4.1	-15	-12
M1630	TGACCTTG SF1 Q6	37	4	-14	-12
M8812	SF1 Q6	37	4	-14	-11
M1608	NFE2 01	35	3.8	-12	-9.5
M6969	BACH1 01	34	3.7	-12	-9.4
M10220	AP1 01	34	3.7	-11	-9.1
M40742	GTF2A2 target genes	49	5.3	-11	-9
M2054	AP1 Q6 01	33	3.5	-11	-8.7
M9769	CTGCAGY unknown	61	6.6	-10	-8.3
M40770	ATXN7L3 target genes	33	3.5	-10	-8.1
M16482	TTCNRGNNNNTTC HSF Q6	24	2.6	-10	-8
M402	TTCYRGAA unknown	36	3.9	-9.8	-7.8
M29968	FOXE1 target genes	57	6.1	-9.8	-7.7
M2489	ERR1 Q2	31	3.3	-9.6	-7.5
M7806	HSF Q6	27	2.9	-9.4	-7.4
M18894	TCANNTGAY SREBP1 01	43	4.6	-9.3	-7.3
M13237	BACH2 01	31	3.3	-9.3	-7.3
M613	TGANNYRGCA TCF11MAFG 01	33	3.5	-9.2	-7.3
M3403	GTGACGY E4F1 Q6	52	5.6	-8.9	-6.9
M8004	TGASTMAGC NFE2 01	25	2.7	-8.7	-6.8